Mark Estabrook

<i>In Vitro</i> Susceptibility of Characterized β-Lactamase-Producing Strains Tested with Avibactam Combinations

Henry Li, Mark Estabrook, George A. Jacoby et al. · Antimicrobial Agents and Chemotherapy · 2014 · 125 citations · Full text

Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program

Mark G. Wise, Mark Estabrook, Daniel F. Sahm et al. · PLoS ONE · 2018 · 90 citations · Full text

Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012–2017

Mark Estabrook, Krystyna M. Kazmierczak, Mark G. Wise et al. · Journal of Global Antimicrobial Resistance · 2021 · 43 citations · Full text

<i>In Vitro</i> Activity of Ceftolozane-Tazobactam as Determined by Broth Dilution and Agar Diffusion Assays against Recent U.S. Escherichia coli Isolates from 2010 to 2011 Carrying CTX-M-Type Extended-Spectrum β-Lactamases

Mark Estabrook, Brianne Bussell, Susan L. Clugston et al. · Journal of Clinical Microbiology · 2014 · 28 citations · Full text

Antimicrobial Susceptibility, Broth Dilution, Antibiotics +13

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible <i>Enterobacterales</i> Collected as Part of a Global Surveillance Study, 2018 to 2019

Mark Estabrook, Astrid Muyldermans, Daniel F. Sahm et al. · Antimicrobial Agents and Chemotherapy · 2023 · 27 citations · Full text